Eckard Weber - Profile and Investment Details

Investor Profile

Eckard Weber is a Venture Capital based in San Diego, United States with a diverse investment portfolio that includes companies such as Epic Sciences, Colorescience, Esperion Therapeutics, Astute Medical, Exalys Therapeutics, WindMIL Therapeutics, Zyga Technology, Atara Biotherapeutics, VentiRx Pharmaceuticals, Celtaxsys, Truvian Sciences, Gene Sciences, Inc., Kona Medical, Veracyte, CoLucid Pharmaceuticals, Dicerna Pharmaceuticals, NovaDigm Therapeutics, Benvenue Medical, Miramar Labs, Ocunexus Therapeutics, Cotera, Regado Biosciences, Obalon Therapeutics, Sequent Medical, Marinus Pharmaceuticals, ReVision Optics, Neothetics, Aspen Neuroscience, Sera Prognostics, Afferent Pharmaceuticals, Sebacia, Omniome, Xagenic, Fractyl Laboratories, Axial Biotherapeutics, Seraphina Therapeutics, ChromaCode, Achaogen, Milestone Pharmaceuticals, Evofem Biosciences, Applied Proteomics, Apnex Medical, Bionano Genomics, Smart Medical Systems, Twelve, Nobias Therapeutics, RightCare Solutions, Antios Therapeutics, Adynxx, Tandem Diabetes Care, Glaukos, Otonomy, Singular Genomics, aTyr Pharma, ROX Medical, Iterum Therapeutics, Syndax Pharmaceuticals. Over time, Eckard Weber has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Eckard Weber is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Wellness, Women Founded, Medical Testing, Life Science, Biotech, Medical Device, Healthcare, Biotechnology, Health Diagnostics, Medical, Therapeutics, Pharmaceuticals, Biopharma may find it worthwhile to explore potential connections with Eckard Weber, as their portfolio suggests a familiarity and interest in this area.

Understanding Eckard Weber’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.